Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FD4YD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,647
Award facts
- Contract value 100% obligated
- $30,646.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $30,646.94 by the Defense Logistics Agency on September 18, 2025. The delivery order is for Nucala 100 mg/mL auto-injectors, a prescription medication used in the treatment of severe eosinophilic asthma and other eosinophilic conditions. The contract carries no set-aside designation and is scheduled for completion by September 19, 2025, with performance to take place at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, which operates under the SPE2DB program, authorizes the agency to issue firm fixed-price delivery orders for a broad range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement and providing comprehensive pharmaceutical distribution services to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FD4YD?
SPE2DB25FD4YD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FD4YD worth?
The government has obligated $30,647 on SPE2DB25FD4YD.
Is contract SPE2DB25FD4YD an order under another contract?
Yes. SPE2DB25FD4YD is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4YD competed?
The extent of competition for SPE2DB25FD4YD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award